Impact of continued administration of tolvaptan on cirrhotic patients with ascites [PDF]
, 2018 KODAMA Kazuhisa +4 more
core +2 more sources
Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care [PDF]
, 2016 Emmanouil Bagkeris +3 more
core +1 more source
The Association of Hyponatremia with Race, Ethnicity, and Gender in Patients Admitted for Acute Decompensated Heart Failure Diagnoses [PDF]
, 2018 Background: Hyponatremia, defined by a serum sodium concentration less than 135 mEq/L, is seen in approximately 25% of patients admitted with congestive heart failure (CHF).
Alvarez, MD, Rene +2 more
core +1 more source
Tolvaptan and Hyponatremia in A Patient With Cirrhosis [PDF]
Hepatology, 2010 openaire +3 more sources
Tolvaptan-Loaded Tomato-Derived Nanovesicles: Characterization and Evaluation of Cytotoxicity, Wound Healing Potential and the Effects on Cyst Formation in Renal Cell Lines. [PDF]
Int J NanomedicineMammadova R +8 more
europepmc +1 more source
Tolvaptan for the Treatment of Refractory Ascites
Internal Medicine, 2016 Masayuki Kurosaki, Namiki Izumi
openaire +3 more sources
Cirrhosis‐related hyponatremia and the role of tolvaptan [PDF]
Hepatology Research, 2015 Yoshiyuki Takei +3 more
openaire +3 more sources
Effectiveness of Urea and Tolvaptan in the Treatment of Hypotonic Hyponatremia. [PDF]
J Clin MedDelgado-Cuesta J +6 more
europepmc +1 more source